US Patent Issued to Takeda Pharmaceutical on May 12 for "Treatment of patients with severe von Willebrand disease undergoing elective surgery by administration of recombinant VWF" (Austrian, American Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,950, issued on May 12, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Treatment of patients with severe von Willebrand disease undergoing elective surgery by administration of recombinant VWF" was invented by Miranda Chapman (Wellesley, Mass.), Bruce Ewenstein (Brookline, Mass.) and Bettina Ploder (Vienna).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to method for pretreating a subject with severe von Willebrand disease prior to a surgical procedure comprising administering to the subject a dose ranging from about 20 IU/kg to about 60 IU/kg rVWF between about 12 hours and about 24 hours prior to the sur...